NEI/NIH, USA
UPDATES ON CLINICAL TRIALS
Saturday, July 13, 20248:15 AM – 9:45 AM CEST
A PHASE I/IIA TRIAL TO TEST SAFETY AND FEASIBILITY OF AN AUTOLOGOUS IPS CELL-DERIVED RETINAL PIGMENT EPITHELIUM PATCH IN AGE-RELATED MACULAR DEGENERATION PATIENTS
Saturday, July 13, 20248:40 AM – 8:50 AM CEST
